Section 26B-3-142 - Long-acting injectables(1) With respect to payments by the Medicaid program for long-acting injectable typical and atypical antipsychotics, the department shall report on the following to the Health and Human Services Interim Committee before November 1, 2023: (a) options for payment, including the benefits and cost of each option; and(b) whether payment should be included in a bundled payment made to a hospital.(2) The department shall prepare the report with input from health care providers.Added by Chapter 295, 2023 General Session ,§ 3, eff. 5/3/2023, technically renumbered.